RH (RH) Financials

$127.68 -1.20 (-0.93%)

Closing price 05/14/2026 03:59 PM Eastern

Extended Trading

$126.04 -1.64 (-1.28%)

As of 08:14 AM Eastern

Annual Income Statements for RH

This table shows RH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2023	2024	2025
Period end date	1/31/2015	1/30/2016	1/28/2017	2/3/2018	2/2/2019	2/1/2020	1/30/2021	1/29/2022	1/28/2023	2/3/2024	2/1/2025
Net Income / (Loss) Attributable to Common Shareholders	91	91	5.40	-2.60	136	220	272	689	529	128	72
Consolidated Net Income / (Loss)	91	91	5.40	-2.60	136	220	272	689	529	128	72
Net Income / (Loss) Continuing Operations	91	91	5.40	-2.60	136	220	272	689	529	128	72
Total Pre-Tax Income	148	150	8.55	23	161	269	377	830	439	167	89
Total Operating Income	166	186	53	117	262	363	467	927	722	366	323
Total Gross Profit	691	753	680	839	986	1,095	1,326	1,855	1,812	1,389	1,415
Total Revenue	1,867	2,109	2,135	2,440	2,506	2,647	2,849	3,759	3,590	3,029	3,181
Operating Revenue	1,867	2,109	2,135	2,440	2,506	2,647	2,849	3,759	3,590	3,029	3,181
Total Cost of Revenue	1,177	1,356	1,455	1,601	1,520	1,552	1,523	1,903	1,778	1,640	1,766
Operating Cost of Revenue	1,177	1,356	1,455	1,601	1,520	1,552	1,523	1,903	1,778	1,640	1,766
Total Operating Expenses	525	567	627	722	724	732	859	928	1,090	1,023	1,092
Selling, General & Admin Expense	525	567	627	722	724	732	859	928	1,090	1,023	1,092
Total Other Income / (Expense), net	-18	-36	-44	-95	-101	-94	-90	-97	-283	-199	-234
Interest & Investment Income	-	-	-	-	-	-	-	-	-113	-198	-231
Other Income / (Expense), net	-	-	-	-34	-32	-6.47	-20	-2.78	-0.03	-1.08	-3.40
Income Tax Expense	57	59	3.15	25	25	49	105	134	-91	28	4.80
Other Gains / (Losses), net	-	-	-	-	0.00	0.00	-0.89	-8.21	-2.06	-11	-11
Basic Earnings per Share	$2.31	$2.27	$0.13	($0.10)	$6.28	$11.55	$13.82	$32.37	$22.47	$6.42	$3.92
Weighted Average Basic Shares Outstanding	39.46M	40.19M	40.69M	27.05M	21.61M	19.08M	19.67M	21.27M	23.52M	19.88M	18.49M
Diluted Earnings per Share	$2.20	$2.16	$0.13	($0.10)	$5.12	$9.07	$9.96	$22.13	$19.90	$5.91	$3.62
Weighted Average Diluted Shares Outstanding	41.38M	42.26M	40.93M	27.05M	26.53M	24.30M	27.30M	31.11M	26.56M	21.60M	19.99M
Weighted Average Basic & Diluted Shares Outstanding	39.40M	40.10M	41.50M	27.30M	21.60M	19.24M	21.00M	21.71M	22.05M	18.32M	18.83M

This table shows RH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	4/29/2023	7/29/2023	10/28/2023	2/3/2024	5/4/2024	8/3/2024	11/2/2024	2/1/2025	5/3/2025	8/2/2025	11/1/2025
Net Income / (Loss) Attributable to Common Shareholders	42	76	-2.19	69	-3.63	29	33	14	8.04	52	36
Consolidated Net Income / (Loss)	42	76	-2.19	69	-3.63	29	33	14	8.04	52	36
Net Income / (Loss) Continuing Operations	42	76	-2.19	69	-3.63	29	33	14	8.04	52	36
Total Pre-Tax Income	60	107	-8.71	89	-3.27	38	44	10	2.96	72	48
Total Operating Income	99	151	51	114	55	96	101	70	56	129	106
Total Gross Profit	348	380	340	337	316	375	361	363	355	409	390
Total Revenue	739	800	751	661	727	830	812	812	814	899	884
Operating Revenue	739	800	751	661	727	830	812	812	814	899	884
Total Cost of Revenue	392	420	411	324	411	455	450	450	459	490	494
Operating Cost of Revenue	392	420	411	324	411	455	450	450	459	490	494
Total Operating Expenses	248	229	289	223	261	279	260	292	299	280	284
Selling, General & Admin Expense	248	229	289	223	261	279	260	292	299	280	284
Total Other Income / (Expense), net	-39	-44	-60	-25	-58	-59	-58	-60	-53	-57	-58
Interest & Investment Income	-	-	-	-	-57	-59	-58	-	-57	-57	-57
Other Income / (Expense), net	0.65	0.19	-5.31	-0.55	-1.17	0.66	-0.03	-2.87	3.65	0.57	-0.69
Income Tax Expense	17	27	-9.22	17	-2.09	3.72	9.26	-6.08	3.13	19	12
Other Gains / (Losses), net	-1.60	-3.38	-2.69	-2.15	-2.44	-4.86	-1.43	-2.65	8.21	-1.35	-0.19
Basic Earnings per Share	$1.90	$3.65	($0.12)	$3.26	($0.20)	$1.57	$1.79	$0.76	$0.43	$2.76	$1.93
Weighted Average Basic Shares Outstanding	22.05M	20.96M	18.37M	19.88M	18.32M	18.46M	18.53M	18.49M	18.73M	18.74M	18.76M
Diluted Earnings per Share	$1.76	$3.36	($0.12)	$3.00	($0.20)	$1.45	$1.66	$0.71	$0.40	$2.62	$1.83
Weighted Average Diluted Shares Outstanding	23.76M	22.73M	18.37M	21.60M	18.32M	19.96M	19.98M	19.99M	19.91M	19.74M	19.81M
Weighted Average Basic & Diluted Shares Outstanding	22.05M	18.40M	18.22M	18.32M	18.45M	18.75M	18.78M	18.73M	18.73M	18.75M	18.78M

This table details how cash moves in and out of RH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2023	2024	2025
Period end date	1/31/2015	1/30/2016	1/28/2017	2/3/2018	2/2/2019	2/1/2020	1/30/2021	1/29/2022	1/28/2023	2/3/2024	1/31/2026
Net Change in Cash & Equivalents	132	186	-232	-90	-20	366	59	2,075	-670	-1,388	11
Net Cash From Operating Activities	79	127	81	475	250	339	501	662	404	202	452
Net Cash From Continuing Operating Activities	79	127	81	474	250	339	501	662	404	202	452
Net Income / (Loss) Continuing Operations	91	91	5.40	-2.60	136	220	272	689	529	128	125
Consolidated Net Income / (Loss)	91	91	5.40	-2.60	136	220	272	689	529	128	125
Depreciation Expense	34	45	57	83	91	101	100	96	109	119	149
Non-Cash Adjustments To Reconcile Net Income	1.99	16	64	119	109	-4.22	129	66	306	161	113
Changes in Operating Assets and Liabilities, net	-56	-49	-76	245	-129	-24	-42	-217	-539	-205	65
Net Cash From Investing Activities	-201	-227	-311	123	-80	-123	-198	-194	-171	-307	-224
Net Cash From Continuing Investing Activities	-201	-227	-311	123	-80	-123	-198	-194	-171	-307	-224
Purchase of Property, Plant & Equipment	-110	-133	-170	-68	-80	-94	-111	-185	-174	-269	-200
Acquisitions	-0.45	-0.34	-116	-	0.00	0.00	-99	-8.97	-2.71	-38	-36
Sale and/or Maturity of Investments	11	144	224	192	-	-	-	-	-	0.00	7.92
Other Investing Activities, net	-9.25	-20	-	-	0.00	-53	-13	-	-	0.00	3.83
Net Cash From Financing Activities	254	287	-2.24	-687	-189	-175	-244	1,607	-902	-1,283	-219
Net Cash From Continuing Financing Activities	254	287	-2.24	-687	-189	149	-244	1,607	-902	-1,281	-219
Repayment of Debt	-845	-2.63	-0.61	-514	-1,127	-685	-263	-390	20	-27	-536
Repurchase of Common Equity	-	-	0.00	-1,000	-250	-250	0.00	0.00	-1,391	-1,253	0.00
Issuance of Debt	1,100	296	0.00	814	1,202	1,115	13	2,000	16	0.00	325
Other Financing Activities, net	-42	-37	-1.63	13	-64	-81	6.03	-2.78	452	-1.85	-8.65
Other Net Changes in Cash	-	-	-	-	-	-	-	-	-	-	1.63
Cash Interest Paid	8.61	13	17	28	31	43	27	39	134	246	217
Cash Income Taxes Paid	60	29	48	4.03	41	40	74	159	41	28	13

This table details how cash moves in and out of RH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	1/28/2023	4/29/2023	8/3/2024	11/2/2024	2/3/2024	5/4/2024	8/3/2024	11/2/2024	2/1/2025	5/3/2025	8/2/2025
Net Change in Cash & Equivalents	459	8.46	-23	8.68	-1,351	-22	-23	8.68	-57	16	-12
Net Cash From Operating Activities	88	87	11	-31	166	56	11	-31	-19	87	138
Net Cash From Continuing Operating Activities	88	87	11	-31	166	56	11	-31	-19	87	138
Net Income / (Loss) Continuing Operations	412	42	29	33	69	-3.63	29	33	14	8.04	52
Consolidated Net Income / (Loss)	412	42	29	33	69	-3.63	29	33	14	8.04	52
Depreciation Expense	24	28	32	33	23	31	32	33	34	35	35
Non-Cash Adjustments To Reconcile Net Income	187	35	43	51	29	38	43	51	47	28	25
Changes in Operating Assets and Liabilities, net	-536	-18	-93	-149	45	-9.28	-93	-149	-114	16	26
Net Cash From Investing Activities	-4.91	-67	-56	-65	-118	-69	-56	-65	-51	-45	-89
Net Cash From Continuing Investing Activities	-4.91	-67	-56	-65	-118	-69	-56	-65	-51	-45	-89
Purchase of Property, Plant & Equipment	-42	-34	-49	-65	-89	-66	-49	-65	-51	-53	-57
Acquisitions	32	-33	-6.74	-0.20	-28	-2.68	-6.74	-0.20	-0.00	-3.14	-32
Other Investing Activities, net	-	-	-	-	-	0.00	-	-	-	2.75	0.28
Net Cash From Financing Activities	376	-11	21	105	-1,400	-8.92	21	105	14	-27	-60
Net Cash From Continuing Financing Activities	376	-11	21	105	-1,400	-8.92	21	105	14	-27	-60
Repayment of Debt	42	-7.42	-1.76	-48	33	-6.26	-6.26	-48	-41	-206	-134
Issuance of Debt	16	-	-	165	-190	0.00	25	165	45	185	75
Other Financing Activities, net	456	-3.52	-2.46	0.07	-1.69	-2.66	2.04	0.07	10	-5.67	-1.14
Effect of Exchange Rate Changes	-	-0.02	-	-	-	-0.17	0.41	-	-0.76	1.07	0.14

This table presents RH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2023	2024	2025
Period end date	1/31/2015	1/30/2016	1/28/2017	2/3/2018	2/2/2019	2/1/2020	1/30/2021	1/29/2022	1/28/2023	2/3/2024	2/1/2025
Total Assets	1,526	2,068	2,193	1,733	2,423	2,446	2,898	5,540	5,309	4,144	4,555
Total Current Assets	884	1,295	1,138	645	704	597	801	3,091	2,513	1,102	1,291
Cash & Equivalents	149	331	87	18	5.80	48	100	2,178	1,508	124	30
Accounts Receivable	26	29	34	31	40	49	59	58	60	55	63
Inventories, net	559	725	752	527	532	439	544	734	802	754	1,020
Prepaid Expenses	88	79	117	69	104	62	97	121	139	169	178
Plant, Property, & Equipment, net	391	516	682	801	953	968	1,077	1,228	1,636	1,686	1,883
Total Noncurrent Assets	251	257	372	287	766	881	1,020	1,221	1,161	1,356	1,380
Long-Term Investments	18	22	33	-	-	0.00	101	101	101	129	127
Goodwill	124	124	174	142	124	124	141	141	141	141	141
Intangible Assets	49	49	101	101	86	86	72	73	75	76	76
Noncurrent Deferred & Refundable Income Taxes	37	37	28	23	36	45	50	57	167	144	148
Other Noncurrent Operating Assets	23	25	36	21	520	626	656	849	676	867	888
Total Liabilities & Shareholders' Equity	1,526	2,068	2,193	1,733	2,423	2,446	2,898	5,540	5,309	4,144	4,555
Total Liabilities	823	1,182	1,273	1,740	2,462	2,427	2,451	4,370	4,525	4,441	4,718
Total Current Liabilities	344	434	416	519	993	983	922	1,064	886	873	905
Accounts Payable	235	262	227	319	320	330	424	442	375	367	413
Current Deferred Revenue	74	107	146	149	153	162	281	388	326	283	292
Other Current Liabilities	36	65	43	51	176	200	214	220	184	182	200
Total Noncurrent Liabilities	194	748	856	1,221	1,469	1,444	1,530	3,306	3,639	3,568	3,813
Long-Term Debt	29	547	593	937	610	563	564	2,197	2,465	2,406	2,587
Noncurrent Deferred & Payable Income Tax Liabilities	0.13	-	-	-	-	-	-	0.00	6.32	8.44	10
Other Noncurrent Operating Liabilities	125	147	203	229	859	881	965	1,110	1,167	1,154	1,216
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	703	886	920	-7.34	-39	19	447	1,170	785	-297	-164
Total Preferred & Common Equity	703	886	920	-7.34	-39	19	447	1,170	785	-297	-164
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	703	886	920	-7.34	-39	19	447	1,170	785	-297	-164
Common Stock	669	764	791	841	356	431	582	621	247	288	362
Retained Earnings	54	145	150	152	-393	-409	-137	551	540	-583	-511
Accumulated Other Comprehensive Income / (Loss)	-0.50	-2.70	-1.69	-0.17	-2.33	-2.76	2.57	-1.41	-2.40	-1.94	-15

This table presents RH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	7/29/2023	10/28/2023	4/29/2023	7/29/2023	10/28/2023	5/4/2024	8/3/2024	11/2/2024	5/3/2025	8/2/2025	11/1/2025
Total Assets	4,213	4,241	5,320	4,213	4,241	4,187	4,376	4,464	4,650	4,697	4,794
Total Current Assets	1,357	1,287	2,476	1,357	1,287	1,116	1,219	1,278	1,280	1,202	1,124
Cash & Equivalents	417	381	1,517	417	381	102	78	87	46	35	43
Accounts Receivable	54	56	60	54	56	63	67	63	64	61	63
Inventories, net	738	719	766	738	719	802	917	979	1,008	957	875
Prepaid Expenses	144	129	129	144	129	149	157	149	162	149	143
Plant, Property, & Equipment, net	1,655	1,665	1,641	1,655	1,665	1,693	1,754	1,797	1,905	2,018	2,175
Total Noncurrent Assets	1,201	1,288	1,203	1,201	1,288	1,377	1,403	1,389	1,465	1,477	1,494
Long-Term Investments	130	128	133	130	128	129	131	130	123	122	121
Goodwill	141	141	141	141	141	141	141	141	141	144	144
Intangible Assets	75	76	75	75	76	76	76	76	79	80	80
Noncurrent Deferred & Refundable Income Taxes	123	126	151	123	126	144	144	139	148	148	148
Other Noncurrent Operating Assets	731	817	704	731	817	887	911	904	974	984	1,001
Total Liabilities & Shareholders' Equity	4,213	4,241	5,320	4,213	4,241	4,187	4,376	4,464	4,650	4,697	4,794
Total Liabilities	4,497	4,574	4,480	4,497	4,574	4,476	4,611	4,647	4,761	4,738	4,790
Total Current Liabilities	873	935	852	873	935	936	1,011	896	934	954	946
Accounts Payable	357	400	322	357	400	407	496	412	398	381	377
Current Deferred Revenue	331	303	345	331	303	316	303	308	346	352	349
Other Current Liabilities	184	190	183	184	190	171	170	177	189	222	221
Total Noncurrent Liabilities	3,625	3,639	3,629	3,625	3,639	3,540	3,601	3,751	3,827	3,784	3,844
Long-Term Debt	2,457	2,411	2,461	2,457	2,411	2,402	2,422	2,583	2,567	2,513	2,438
Noncurrent Deferred & Payable Income Tax Liabilities	6.40	6.14	6.40	6.40	6.14	8.42	8.54	8.50	11	11	11
Other Noncurrent Operating Liabilities	1,162	1,222	1,161	1,162	1,222	1,130	1,170	1,159	1,248	1,260	1,394
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-285	-333	839	-285	-333	-290	-235	-183	-111	-41	3.35
Total Preferred & Common Equity	-285	-333	839	-285	-333	-290	-235	-183	-111	-41	3.35
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-285	-333	839	-285	-333	-290	-235	-183	-111	-41	3.35
Common Stock	262	271	258	262	271	300	321	341	376	388	400
Retained Earnings	-550	-595	582	-550	-595	-587	-558	-525	-503	-451	-415
Accumulated Other Comprehensive Income / (Loss)	3.27	-9.00	-0.11	3.27	-9.00	-3.22	2.00	1.14	17	23	18

This table displays calculated financial ratios and metrics derived from RH's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2023	2024	2025
Period end date	1/31/2015	1/30/2016	1/28/2017	2/3/2018	2/2/2019	2/1/2020	1/30/2021	1/29/2022	1/28/2023	2/3/2024	2/1/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	20.40%	12.94%	1.23%	14.30%	2.68%	5.66%	7.60%	31.95%	0.00%	-15.63%	5.01%
EBITDA Growth	152.30%	21.75%	-44.81%	40.80%	84.26%	38.70%	17.01%	78.15%	0.00%	-40.39%	-7.15%
EBIT Growth	202.14%	11.97%	-71.42%	57.28%	175.31%	55.17%	25.31%	107.01%	0.00%	-49.46%	-12.55%
NOPAT Growth	400.92%	10.81%	-70.31%	-140.34%	1,733.86%	34.59%	13.60%	130.58%	0.00%	-65.15%	0.36%
Net Income Growth	400.15%	0.11%	-94.07%	-148.12%	5,322.43%	62.36%	23.34%	153.31%	0.00%	-75.87%	-43.23%
EPS Growth	388.89%	-1.82%	-93.98%	-176.92%	5,220.00%	77.15%	9.81%	122.19%	0.00%	-70.30%	-38.75%
Operating Cash Flow Growth	-9.46%	59.89%	-36.46%	489.36%	-47.40%	35.89%	47.64%	32.22%	0.00%	-95.77%	-91.55%
Free Cash Flow Firm Growth	4.93%	27.21%	-442.89%	221.51%	-31.60%	71.96%	4.19%	10.43%	0.00%	0.00%	-241.08%
Invested Capital Growth	27.46%	20.60%	31.73%	-27.09%	-0.19%	-9.39%	-7.40%	44.29%	0.00%	15.86%	19.35%
Revenue Q/Q Growth	6.32%	3.15%	-2.76%	3.55%	0.02%	-0.22%	5.46%	2.46%	0.00%	-17.42%	2.39%
EBITDA Q/Q Growth	14.78%	-0.06%	-20.75%	5.21%	0.39%	0.77%	10.66%	2.81%	0.00%	-37.85%	-0.16%
EBIT Q/Q Growth	11.48%	-4.18%	-43.07%	-6.58%	1.11%	1.41%	16.22%	3.51%	0.00%	-46.05%	-0.06%
NOPAT Q/Q Growth	23.51%	-4.99%	-39.80%	-135.92%	25.01%	6.94%	17.77%	5.25%	0.00%	-65.77%	1.73%
Net Income Q/Q Growth	21.14%	-9.19%	-81.55%	-122.89%	30.56%	22.98%	29.40%	2.51%	0.00%	-72.91%	3.63%
EPS Q/Q Growth	18.92%	-10.00%	-81.16%	-123.81%	36.90%	20.13%	27.86%	0.87%	0.00%	-66.82%	-5.24%
Operating Cash Flow Q/Q Growth	130.98%	50.17%	-35.77%	-3.08%	37.80%	-6.79%	5.32%	-3.65%	0.00%	-86.14%	121.89%
Free Cash Flow Firm Q/Q Growth	4.46%	55.38%	-40.56%	25.46%	-70.03%	198.13%	418.85%	-24.74%	100.00%	-85.92%	77.38%
Invested Capital Q/Q Growth	3.22%	-4.29%	1.01%	-10.29%	101.98%	37.41%	-5.72%	14.22%	1.87%	-13.05%	3.77%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	36.99%	35.69%	31.84%	34.40%	39.33%	41.36%	46.53%	49.36%	50.47%	45.86%	44.48%
EBITDA Margin	11.15%	12.02%	6.55%	8.07%	14.48%	19.01%	20.68%	27.91%	23.14%	16.35%	14.13%
Operating Margin	8.87%	8.80%	2.48%	4.80%	10.45%	13.71%	16.39%	24.67%	20.11%	12.09%	10.14%
EBIT Margin	8.87%	8.80%	2.48%	3.42%	9.17%	13.46%	15.68%	24.59%	20.11%	12.05%	10.04%
Profit (Net Income) Margin	4.87%	4.32%	0.25%	-0.11%	5.42%	8.32%	9.54%	18.32%	14.72%	4.21%	2.28%
Tax Burden Percent	61.42%	60.78%	63.14%	-11.53%	84.32%	81.87%	72.04%	82.93%	120.33%	76.52%	81.74%
Interest Burden Percent	89.41%	80.77%	16.13%	27.01%	70.09%	75.54%	84.49%	89.82%	60.84%	45.67%	27.75%
Effective Tax Rate	38.58%	39.22%	36.86%	111.53%	15.68%	18.13%	27.72%	16.09%	-20.79%	16.95%	5.42%
Return on Invested Capital (ROIC)	14.50%	13.00%	3.05%	-1.25%	24.24%	34.26%	42.51%	83.46%	53.24%	17.19%	14.65%
ROIC Less NNEP Spread (ROIC-NNEP)	0.67%	-16.58%	-11.25%	0.50%	15.14%	25.52%	30.81%	11.03%	12.99%	5.62%	4.59%
Return on Net Nonoperating Assets (RNNOA)	0.08%	-1.53%	-2.45%	0.68%	-614.04%	-2,233.73%	74.23%	1.69%	14.13%	35.17%	-46.07%
Return on Equity (ROE)	14.58%	11.47%	0.60%	-0.57%	-589.80%	-2,199.46%	116.74%	85.15%	67.37%	52.36%	-31.42%
Cash Return on Invested Capital (CROIC)	-9.65%	-5.68%	-24.34%	30.09%	24.43%	44.12%	50.20%	47.20%	0.00%	2.49%	-2.99%
Operating Return on Assets (OROA)	12.99%	10.33%	2.49%	4.25%	11.05%	14.64%	16.71%	21.91%	13.60%	7.72%	7.34%
Return on Assets (ROA)	7.13%	5.07%	0.25%	-0.13%	6.53%	9.05%	10.17%	16.32%	9.96%	2.70%	1.66%
Return on Common Equity (ROCE)	14.58%	11.47%	0.60%	-0.57%	-589.80%	-2,199.46%	116.74%	85.15%	67.37%	52.36%	-31.42%
Return on Equity Simple (ROE_SIMPLE)	0.00%	10.28%	0.59%	35.43%	-350.82%	1,181.57%	60.81%	58.84%	67.37%	-42.89%	0.00%
Net Operating Profit after Tax (NOPAT)	102	113	33	-14	221	297	337	778	872	304	305
NOPAT Margin	5.45%	5.35%	1.57%	-0.55%	8.81%	11.22%	11.85%	20.70%	24.30%	10.04%	9.59%
Net Nonoperating Expense Percent (NNEP)	13.83%	29.58%	14.30%	-1.75%	9.10%	8.74%	11.70%	72.43%	40.25%	11.57%	10.06%
Return On Investment Capital (ROIC_SIMPLE)	13.91%	-	-	-	-	-	-	-	26.83%	14.13%	12.59%
Cost of Revenue to Revenue	63.01%	64.31%	68.16%	65.61%	60.67%	58.64%	53.47%	50.64%	49.53%	54.14%	55.52%
SG&A Expenses to Revenue	28.12%	26.89%	29.36%	29.60%	28.89%	27.66%	30.14%	24.69%	30.35%	33.77%	34.34%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	28.12%	26.89%	29.36%	29.60%	28.89%	27.66%	30.14%	24.69%	30.35%	33.77%	34.34%
Earnings before Interest and Taxes (EBIT)	166	186	53	83	230	356	447	924	722	365	319
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	208	253	140	197	363	503	589	1,049	831	495	449
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.93	2.81	1.16	0.00	0.00	212.62	21.69	7.19	9.35	0.00	0.00
Price to Tangible Book Value (P/TBV)	6.54	3.50	1.65	0.00	0.00	0.00	41.40	8.80	12.89	0.00	0.00
Price to Revenue (P/Rev)	1.86	1.18	0.50	0.80	1.13	1.50	3.40	2.24	2.04	1.54	2.45
Price to Earnings (P/E)	38.07	27.38	197.10	0.00	20.89	17.99	35.68	12.22	13.88	36.57	107.67
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.63%	3.65%	0.51%	0.00%	4.79%	5.56%	2.80%	8.18%	7.21%	2.73%	0.93%
Enterprise Value to Invested Capital (EV/IC)	4.15	2.69	1.12	3.16	4.16	5.79	13.19	7.58	5.00	3.61	4.51
Enterprise Value to Revenue (EV/Rev)	1.75	1.21	0.65	1.18	1.51	1.80	3.53	2.22	2.28	2.26	3.22
Enterprise Value to EBITDA (EV/EBITDA)	15.68	10.09	9.97	14.62	10.43	9.48	17.09	7.95	9.86	13.85	22.76
Enterprise Value to EBIT (EV/EBIT)	19.69	13.78	26.30	34.53	16.48	13.39	22.54	9.03	11.34	18.80	32.04
Enterprise Value to NOPAT (EV/NOPAT)	32.07	22.67	41.65	0.00	17.14	16.06	29.82	10.73	9.39	22.57	33.52
Enterprise Value to Operating Cash Flow (EV/OCF)	41.19	20.18	17.32	6.07	15.16	14.07	20.10	12.60	20.29	401.32	598.19
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	8.86	17.01	12.48	25.26	18.97	0.00	155.53	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.04	0.62	0.64	-127.67	-24.66	45.75	1.27	1.89	3.14	-8.23	-15.81
Long-Term Debt to Equity	0.04	0.62	0.64	-127.67	-15.77	30.17	1.26	1.88	3.14	-8.09	-15.81
Financial Leverage	0.12	0.09	0.22	1.37	-40.56	-87.52	2.41	0.15	1.09	6.26	-10.03
Leverage Ratio	2.04	2.26	2.36	4.30	-90.29	-242.96	11.48	5.22	6.77	19.40	-18.87
Compound Leverage Factor	1.83	1.83	0.38	1.16	-63.29	-183.53	9.70	4.69	4.12	8.86	-5.24
Debt to Total Capital	3.95%	38.17%	39.20%	100.79%	104.23%	97.86%	55.91%	65.38%	75.87%	113.83%	106.75%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	37.56%	33.32%	0.23%	0.38%	0.05%	1.95%	0.00%
Long-Term Debt to Total Capital	3.95%	38.17%	39.20%	100.79%	66.67%	64.54%	55.67%	64.99%	75.82%	111.88%	106.75%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	96.05%	61.83%	60.80%	-0.79%	-4.23%	2.14%	44.09%	34.62%	24.13%	-13.83%	-6.75%
Debt to EBITDA	0.14	2.16	4.24	4.76	2.63	1.70	0.96	2.11	2.97	4.94	5.76
Net Debt to EBITDA	-0.96	0.25	2.36	4.66	2.61	1.60	0.62	-0.07	1.03	4.43	5.41
Long-Term Debt to EBITDA	0.14	2.16	4.24	4.76	1.68	1.12	0.96	2.09	2.97	4.86	5.76
Debt to NOPAT	0.28	4.85	17.71	-69.33	4.32	2.87	1.68	2.84	2.83	8.05	8.48
Net Debt to NOPAT	-1.97	0.56	9.86	-68.01	4.30	2.71	1.08	-0.09	0.98	7.22	7.96
Long-Term Debt to NOPAT	0.28	4.85	17.71	-69.33	2.77	1.89	1.67	2.82	2.83	7.92	8.48
Altman Z-Score	4.58	3.18	2.05	2.45	1.67	2.12	3.75	2.96	2.61	1.52	1.87
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.57	2.98	2.74	1.24	0.71	0.61	0.87	2.91	2.84	1.26	1.43
Quick Ratio	0.69	1.13	0.63	0.10	0.05	0.10	0.17	2.10	1.77	0.20	0.10
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-68	-49	-268	325	222	382	398	440	0.00	44	-62
Operating Cash Flow to CapEx	71.80%	94.94%	47.35%	890.75%	312.04%	487.72%	581.48%	357.16%	239.78%	7.41%	7.41%
Free Cash Flow to Firm to Interest Expense	-3.86	-1.38	-6.02	5.34	3.24	4.39	5.75	4.68	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	4.52	3.55	1.81	7.79	3.63	3.89	7.23	7.04	2.38	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-1.77	-0.19	-2.01	6.92	2.47	3.09	5.99	5.07	1.39	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.46	1.17	1.00	1.24	1.21	1.09	1.07	0.89	0.68	0.64	0.73
Accounts Receivable Turnover	77.82	77.35	68.04	74.39	69.96	59.36	52.53	64.04	60.08	52.76	53.66
Inventory Turnover	2.32	2.11	1.97	2.50	2.87	3.20	3.10	2.98	2.22	2.11	1.99
Fixed Asset Turnover	6.17	4.65	3.57	3.29	2.86	2.76	2.79	3.26	2.19	1.82	1.78
Accounts Payable Turnover	5.33	5.45	5.95	5.87	4.76	4.77	4.04	4.39	4.74	4.42	4.53
Days Sales Outstanding (DSO)	4.69	4.72	5.36	4.91	5.22	6.15	6.95	5.70	6.08	6.92	6.80
Days Inventory Outstanding (DIO)	157.14	172.86	185.34	145.84	127.14	114.11	117.78	122.58	164.56	173.14	183.32
Days Payable Outstanding (DPO)	68.55	66.93	61.36	62.22	76.75	76.51	90.43	83.11	76.95	82.51	80.61
Cash Conversion Cycle (CCC)	93.29	110.65	129.34	88.54	55.61	43.75	34.29	45.18	93.69	97.54	109.50
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	787	949	1,250	911	910	824	763	1,101	1,639	1,898	2,266
Invested Capital Turnover	2.66	2.43	1.94	2.26	2.75	3.05	3.59	4.03	2.19	1.71	1.53
Increase / (Decrease) in Invested Capital	170	162	301	-339	-1.70	-85	-61	338	0.00	260	367
Enterprise Value (EV)	3,264	2,557	1,395	2,880	3,784	4,771	10,064	8,345	8,189	6,861	10,226
Market Capitalization	3,464	2,494	1,065	1,961	2,835	3,966	9,698	8,414	7,335	4,665	7,797
Book Value per Share	$17.76	$21.89	$22.54	($0.34)	($1.82)	$0.98	$21.91	$54.51	$33.23	($16.32)	($8.79)
Tangible Book Value per Share	$13.39	$17.62	$15.82	($11.73)	($11.74)	($10.09)	$11.48	$44.53	$24.10	($28.23)	($20.46)
Total Capital	732	1,433	1,513	929	915	872	1,014	3,380	3,252	2,151	2,423
Total Debt	29	547	593	937	954	853	567	2,210	2,467	2,448	2,587
Total Long-Term Debt	29	547	593	937	610	563	564	2,197	2,465	2,406	2,587
Net Debt	-200	63	330	919	948	806	366	-69	854	2,196	2,429
Capital Expenditures (CapEx)	110	133	170	53	80	70	86	185	168	231	231
Debt-free, Cash-free Net Working Capital (DFCFNWC)	329	399	492	108	49	-143	-218	-137	117	147	356
Debt-free Net Working Capital (DFNWC)	540	861	722	126	55	-95	-118	2,041	1,628	271	386
Net Working Capital (NWC)	540	861	722	126	-289	-386	-120	2,028	1,627	229	386
Net Nonoperating Expense (NNE)	11	22	28	-11	85	77	66	89	344	176	233
Net Nonoperating Obligations (NNO)	84	63	330	919	948	806	316	-69	854	2,196	2,429
Total Depreciation and Amortization (D&A)	42	68	87	114	133	147	142	125	109	130	130
Debt-free, Cash-free Net Working Capital to Revenue	17.61%	18.91%	23.06%	4.41%	1.97%	-5.40%	-7.66%	-3.65%	3.25%	4.86%	11.19%
Debt-free Net Working Capital to Revenue	28.92%	40.83%	33.82%	5.15%	2.20%	-3.60%	-4.14%	54.29%	45.35%	8.94%	12.14%
Net Working Capital to Revenue	28.92%	40.83%	33.82%	5.15%	-11.52%	-14.58%	-4.22%	53.94%	45.31%	7.56%	12.14%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.31	$2.27	$0.13	$0.08	$6.97	$11.55	$13.82	$32.37	$22.47	$6.42	$3.92
Adjusted Weighted Average Basic Shares Outstanding	39.46M	40.19M	40.69M	27.05M	21.61M	19.08M	19.67M	21.27M	23.52M	19.88M	18.49M
Adjusted Diluted Earnings per Share	$2.20	$2.16	$0.13	$0.07	$5.68	$9.07	$9.96	$22.13	$19.90	$5.91	$3.62
Adjusted Weighted Average Diluted Shares Outstanding	41.38M	42.26M	40.93M	29.25M	26.53M	24.30M	27.30M	31.11M	26.56M	21.60M	19.99M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$6.97	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	39.89M	40.58M	35.90M	21.52M	20.48M	19.24M	21.00M	21.71M	22.05M	18.32M	18.73M
Normalized Net Operating Profit after Tax (NOPAT)	102	113	33	82	221	297	337	778	506	304	305
Normalized NOPAT Margin	5.45%	5.35%	1.57%	3.36%	8.81%	11.22%	11.85%	20.70%	14.08%	10.04%	9.59%
Pre Tax Income Margin	7.93%	7.11%	0.40%	0.92%	6.42%	10.17%	13.25%	22.09%	12.24%	5.50%	2.79%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.44	5.20	1.19	1.37	3.34	4.09	6.45	9.83	4.26	0.00	0.00
NOPAT to Interest Expense	5.80	3.16	0.75	-0.22	3.21	3.41	4.87	8.27	5.14	0.00	0.00
EBIT Less CapEx to Interest Expense	3.15	1.46	-2.63	0.50	2.18	3.29	5.20	7.85	3.27	0.00	0.00
NOPAT Less CapEx to Interest Expense	-0.49	-0.58	-3.07	-1.10	2.05	2.61	3.63	6.30	4.15	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	-38,488.88%	184.19%	113.46%	0.00%	0.00%	263.11%	9.40%	16.56%

This table displays calculated financial ratios and metrics derived from RH's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	10/28/2023	1/28/2023	5/4/2024	8/3/2024	11/2/2024	2/3/2024	5/4/2024	8/2/2025	11/2/2024	2/1/2025	5/3/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-13.56%	0.00%	-1.65%	3.64%	8.05%	-49.16%	-1.65%	12.33%	8.05%	10.04%	11.97%
EBITDA Growth	-62.11%	0.00%	-33.95%	-28.17%	80.73%	-69.67%	-33.95%	-9.99%	80.73%	-0.68%	12.42%
EBIT Growth	-72.70%	0.00%	-46.44%	-36.12%	120.86%	-73.34%	-46.44%	-14.57%	120.86%	-0.27%	11.34%
NOPAT Growth	-71.37%	0.00%	-46.74%	-23.25%	123.20%	-84.97%	-46.74%	-15.94%	123.20%	-2.43%	-108.19%
Net Income Growth	-102.21%	0.00%	-108.65%	-62.14%	1,616.60%	-83.26%	-108.65%	-32.39%	1,616.60%	22.28%	321.77%
EPS Growth	-103.17%	0.00%	-111.36%	-56.85%	1,483.33%	-79.87%	-111.36%	-22.02%	1,483.33%	-21.98%	300.00%
Operating Cash Flow Growth	-52.74%	0.00%	-35.29%	-93.08%	-146.36%	90.08%	-35.29%	-93.08%	-146.36%	83.53%	54.36%
Free Cash Flow Firm Growth	86.20%	0.00%	55.49%	-2,171.33%	-744.93%	0.00%	-428.40%	-631.23%	-744.93%	-75.48%	-55.72%
Invested Capital Growth	6.24%	0.00%	16.63%	24.62%	35.75%	15.86%	16.63%	42.82%	35.75%	19.35%	18.94%
Revenue Q/Q Growth	-6.15%	73.00%	-34.42%	14.13%	-2.16%	-18.60%	-1.53%	23.69%	-2.16%	0.08%	0.19%
EBITDA Q/Q Growth	-58.60%	503.62%	-77.45%	53.04%	4.18%	1.29%	-17.55%	91.77%	4.18%	-24.45%	-6.67%
EBIT Q/Q Growth	-69.69%	824.82%	-84.50%	80.92%	4.81%	11.66%	-20.91%	141.97%	4.81%	-33.50%	-11.71%
NOPAT Q/Q Growth	-68.22%	1,597.66%	-93.52%	126.34%	-7.57%	14.29%	-66.40%	147.89%	-7.57%	38.82%	-102.82%
Net Income Q/Q Growth	-102.86%	18,959.72%	-100.99%	898.68%	14.56%	108.23%	-131.85%	1,526.43%	14.56%	-58.04%	-42.24%
EPS Q/Q Growth	-103.57%	12,516.67%	-101.46%	825.00%	14.48%	80.72%	-121.98%	1,410.00%	14.48%	-57.23%	-43.66%
Operating Cash Flow Q/Q Growth	-58.04%	29.05%	-17.05%	-80.09%	-381.29%	629.14%	149.26%	-80.09%	-381.29%	40.28%	561.49%
Free Cash Flow Firm Q/Q Growth	-325.77%	100.00%	0.00%	-32.45%	-58.39%	65.97%	-61.59%	-154.08%	-58.39%	48.24%	-43.40%
Invested Capital Q/Q Growth	-0.80%	1.87%	17.37%	5.06%	8.06%	-13.05%	1.30%	20.41%	8.06%	3.77%	0.96%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	45.32%	57.24%	43.47%	45.17%	44.51%	50.98%	43.47%	45.52%	44.51%	44.66%	43.66%
EBITDA Margin	9.90%	34.55%	11.60%	15.55%	16.56%	20.61%	11.60%	17.98%	16.56%	12.50%	11.65%
Operating Margin	6.82%	32.34%	7.52%	11.59%	12.50%	17.22%	7.52%	14.33%	12.50%	8.66%	6.87%
EBIT Margin	6.11%	32.68%	7.36%	11.67%	12.50%	17.14%	7.36%	14.40%	12.50%	8.30%	7.32%
Profit (Net Income) Margin	-0.29%	31.74%	-0.50%	3.49%	4.09%	10.45%	-0.50%	5.75%	4.09%	1.71%	0.99%
Tax Burden Percent	25.11%	146.85%	110.72%	77.15%	75.64%	77.96%	110.72%	71.73%	75.64%	132.72%	271.50%
Interest Burden Percent	-18.96%	66.12%	-6.12%	38.77%	43.23%	78.22%	-6.12%	55.69%	43.23%	15.54%	4.97%
Effective Tax Rate	0.00%	-44.85%	0.00%	9.90%	21.11%	19.62%	0.00%	26.40%	21.11%	-58.01%	105.61%
Return on Invested Capital (ROIC)	0.00%	102.66%	10.55%	20.68%	19.08%	23.71%	8.89%	16.70%	16.16%	20.90%	-0.60%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	79.66%	7.77%	17.91%	16.90%	22.24%	6.12%	14.67%	13.98%	16.69%	-0.11%
Return on Net Nonoperating Assets (RNNOA)	0.00%	86.69%	42.76%	-143.51%	-141.06%	139.22%	33.66%	-192.14%	-116.69%	-167.49%	1.30%
Return on Equity (ROE)	0.00%	189.35%	53.31%	-122.83%	-121.98%	162.94%	42.55%	-175.45%	-100.53%	-146.59%	0.70%
Cash Return on Invested Capital (CROIC)	-6.05%	0.00%	33.69%	27.16%	16.52%	2.49%	0.98%	-20.38%	-14.51%	-2.99%	-3.55%
Operating Return on Assets (OROA)	0.00%	22.10%	5.54%	9.80%	10.53%	10.99%	4.67%	10.07%	8.92%	6.07%	5.41%
Return on Assets (ROA)	0.00%	21.46%	-0.38%	2.93%	3.44%	6.70%	-0.32%	4.02%	2.92%	1.25%	0.73%
Return on Common Equity (ROCE)	0.00%	189.35%	53.31%	-122.83%	-121.98%	162.94%	42.55%	-175.45%	-100.53%	-146.59%	0.70%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	-166.64%	-185.59%	-257.34%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	36	609	38	87	80	91	38	95	80	111	-3.13
NOPAT Margin	4.77%	46.85%	5.26%	10.44%	9.86%	13.85%	5.26%	10.55%	9.86%	13.68%	-0.39%
Net Nonoperating Expense Percent (NNEP)	3.52%	23.00%	2.77%	2.77%	2.18%	1.47%	2.77%	2.02%	2.18%	4.20%	-0.48%
Return On Investment Capital (ROIC_SIMPLE)	1.69%	18.72%	-	-	3.34%	4.25%	1.78%	3.84%	3.34%	4.59%	-0.13%
Cost of Revenue to Revenue	54.68%	42.76%	56.53%	54.83%	55.49%	49.02%	56.53%	54.48%	55.49%	55.34%	56.34%
SG&A Expenses to Revenue	38.50%	24.90%	35.95%	33.58%	32.01%	33.76%	35.95%	31.18%	32.01%	36.00%	36.79%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	38.50%	24.90%	35.95%	33.58%	32.01%	33.76%	35.95%	31.18%	32.01%	36.00%	36.79%
Earnings before Interest and Taxes (EBIT)	46	425	53	97	101	113	53	129	101	67	60
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	74	449	84	129	134	136	84	162	134	102	95
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	9.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	12.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	2.04	1.41	1.32	1.63	1.54	1.67	1.21	1.92	2.45	1.13
Price to Earnings (P/E)	0.00	13.88	10.43	10.91	12.67	36.57	61.40	65.66	85.38	107.67	43.79
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	7.21%	9.59%	9.17%	7.89%	2.73%	1.63%	1.52%	1.17%	0.93%	2.28%
Enterprise Value to Invested Capital (EV/IC)	3.65	5.00	3.77	3.47	3.82	3.61	3.77	2.64	3.82	4.51	2.66
Enterprise Value to Revenue (EV/Rev)	0.00	2.28	2.03	1.94	2.27	2.26	2.40	1.96	2.68	3.22	1.86
Enterprise Value to EBITDA (EV/EBITDA)	0.00	9.86	9.21	9.51	10.46	13.85	16.46	14.47	18.51	22.76	13.22
Enterprise Value to EBIT (EV/EBIT)	0.00	11.34	10.73	11.28	12.32	18.80	22.76	20.63	26.09	32.04	18.69
Enterprise Value to NOPAT (EV/NOPAT)	0.00	9.39	8.28	7.84	9.38	22.57	24.86	20.88	27.78	33.52	20.99
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	20.29	19.44	31.47	67.53	401.32	42.25	289.03	0.00	598.19	127.70
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	12.05	14.17	26.60	155.53	414.89	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-7.36	3.14	-8.43	-10.50	-14.11	-8.23	-8.43	-61.44	-14.11	-15.81	-23.18
Long-Term Debt to Equity	-7.23	3.14	-8.28	-10.32	-14.11	-8.09	-8.28	-61.44	-14.11	-15.81	-23.18
Financial Leverage	2.25	1.09	5.50	-8.01	-8.35	6.26	5.50	-13.10	-8.35	-10.03	-11.51
Leverage Ratio	10.54	6.77	17.30	-16.54	-16.86	19.40	17.30	-27.37	-16.86	-18.87	-22.05
Compound Leverage Factor	-2.00	4.47	-1.06	-6.41	-7.29	15.17	-1.06	-15.25	-7.29	-2.93	-1.10
Debt to Total Capital	115.72%	75.87%	113.46%	110.53%	107.63%	113.83%	113.46%	101.65%	107.63%	106.75%	104.51%
Short-Term Debt to Total Capital	1.97%	0.05%	1.94%	1.88%	0.00%	1.95%	1.94%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	113.75%	75.82%	111.52%	108.65%	107.63%	111.88%	111.52%	101.65%	107.63%	106.75%	104.51%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-15.72%	24.13%	-13.46%	-10.53%	-7.63%	-13.83%	-13.46%	-1.65%	-7.63%	-6.75%	-4.51%
Debt to EBITDA	0.00	2.97	3.10	3.34	3.24	4.94	5.55	5.94	5.74	5.76	5.58
Net Debt to EBITDA	0.00	1.03	2.81	3.06	2.97	4.43	5.02	5.58	5.26	5.41	5.22
Long-Term Debt to EBITDA	0.00	2.97	3.05	3.29	3.24	4.86	5.45	5.94	5.74	5.76	5.58
Debt to NOPAT	0.00	2.83	2.79	2.76	2.91	8.05	8.38	8.58	8.61	8.48	8.86
Net Debt to NOPAT	0.00	0.98	2.53	2.52	2.66	7.22	7.59	8.04	7.89	7.96	8.28
Long-Term Debt to NOPAT	0.00	2.83	2.74	2.71	2.91	7.92	8.23	8.58	8.61	8.48	8.86
Altman Z-Score	0.45	2.42	1.43	1.39	1.60	1.32	1.29	1.16	1.48	1.68	1.15
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.38	2.84	1.19	1.21	1.43	1.26	1.19	1.26	1.43	1.43	1.37
Quick Ratio	0.47	1.77	0.18	0.14	0.17	0.20	0.18	0.10	0.17	0.10	0.12
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-59	0.00	-236	-313	-495	-168	-236	-599	-495	-256	-367
Operating Cash Flow to CapEx	134.98%	209.36%	84.71%	22.77%	-48.70%	185.95%	84.71%	22.77%	-48.70%	-36.89%	164.83%
Free Cash Flow to Firm to Interest Expense	-1.07	0.00	-4.16	-5.27	-8.59	0.00	0.00	0.00	-8.59	0.00	0.00
Operating Cash Flow to Interest Expense	1.24	2.85	0.99	0.19	-0.55	0.00	0.00	0.00	-0.55	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.32	1.49	-0.18	-0.64	-1.67	0.00	0.00	0.00	-1.67	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.68	0.75	0.84	0.84	0.64	0.63	0.70	0.71	0.73	0.74
Accounts Receivable Turnover	0.00	60.08	58.17	59.58	61.62	52.76	49.04	53.86	52.19	53.66	51.63
Inventory Turnover	0.00	2.22	2.29	2.21	2.21	2.11	2.12	2.04	2.04	1.99	2.00
Fixed Asset Turnover	0.00	2.19	2.15	2.12	2.12	1.82	1.81	1.70	1.79	1.78	1.82
Accounts Payable Turnover	0.00	4.74	4.93	4.29	4.61	4.42	4.55	4.69	4.27	4.53	4.50
Days Sales Outstanding (DSO)	0.00	6.08	6.28	6.13	5.92	6.92	7.44	6.78	6.99	6.80	7.07
Days Inventory Outstanding (DIO)	0.00	164.56	159.22	164.84	165.50	173.14	172.50	178.88	178.71	183.32	182.15
Days Payable Outstanding (DPO)	0.00	76.95	74.03	85.00	79.12	82.51	80.20	77.90	85.44	80.61	81.09
Cash Conversion Cycle (CCC)	0.00	93.69	91.47	85.96	92.30	97.54	99.74	107.75	100.26	109.50	108.13
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,608	1,639	1,923	2,021	2,183	1,898	1,923	2,316	2,183	2,266	2,287
Invested Capital Turnover	0.00	2.19	2.00	1.98	1.93	1.71	1.69	1.58	1.64	1.53	1.55
Increase / (Decrease) in Invested Capital	94	0.00	274	399	575	260	274	694	575	367	364
Enterprise Value (EV)	5,863	8,189	7,251	7,007	8,332	6,861	7,251	6,117	8,332	10,226	6,079
Market Capitalization	3,922	7,335	5,038	4,751	5,966	4,665	5,038	3,761	5,966	7,797	3,681
Book Value per Share	($18.11)	$33.23	($15.83)	($12.73)	($9.90)	($16.32)	($15.83)	($2.18)	($9.90)	($8.79)	($5.91)
Tangible Book Value per Share	($29.89)	$24.10	($27.68)	($24.50)	($21.67)	($28.23)	($27.68)	($14.11)	($21.67)	($20.46)	($17.66)
Total Capital	2,119	3,252	2,154	2,230	2,400	2,151	2,154	2,472	2,400	2,423	2,456
Total Debt	2,452	2,467	2,444	2,464	2,583	2,448	2,444	2,513	2,583	2,587	2,567
Total Long-Term Debt	2,411	2,465	2,402	2,422	2,583	2,406	2,402	2,513	2,583	2,587	2,567
Net Debt	1,942	854	2,213	2,255	2,366	2,196	2,213	2,357	2,366	2,429	2,398
Capital Expenditures (CapEx)	50	42	66	49	65	89	66	49	65	51	53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	11	117	120	172	294	147	120	213	294	356	300
Debt-free Net Working Capital (DFNWC)	394	1,628	221	251	381	271	221	248	381	386	346
Net Working Capital (NWC)	352	1,627	180	209	381	229	180	248	381	386	346
Net Nonoperating Expense (NNE)	38	196	42	58	47	22	42	43	47	97	-11
Net Nonoperating Obligations (NNO)	1,942	854	2,213	2,255	2,366	2,196	2,213	2,357	2,366	2,429	2,398
Total Depreciation and Amortization (D&A)	28	24	31	32	33	23	31	32	33	34	35
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	3.25%	3.34%	4.78%	8.03%	4.86%	3.96%	6.84%	9.48%	11.19%	9.17%
Debt-free Net Working Capital to Revenue	0.00%	45.35%	6.19%	6.95%	10.40%	8.94%	7.34%	7.95%	12.28%	12.14%	10.58%
Net Working Capital to Revenue	0.00%	45.31%	5.02%	5.79%	10.40%	7.56%	5.95%	7.95%	12.28%	12.14%	10.58%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$17.04	($0.20)	$1.57	$1.79	$3.26	($0.20)	$2.76	$1.79	$0.76	$0.43
Adjusted Weighted Average Basic Shares Outstanding	0.00	23.52M	18.32M	18.46M	18.53M	19.88M	18.32M	18.74M	18.53M	18.49M	18.73M
Adjusted Diluted Earnings per Share	$0.00	$14.90	($0.20)	$1.45	$1.66	$3.00	($0.20)	$2.62	$1.66	$0.71	$0.40
Adjusted Weighted Average Diluted Shares Outstanding	0.00	26.56M	18.32M	19.96M	19.98M	21.60M	18.32M	19.74M	19.98M	19.99M	19.91M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	22.05M	18.45M	18.48M	18.60M	18.32M	18.45M	18.75M	18.60M	18.73M	18.73M
Normalized Net Operating Profit after Tax (NOPAT)	36	294	38	87	80	91	38	95	80	49	39
Normalized NOPAT Margin	4.77%	22.64%	5.26%	10.44%	9.86%	13.85%	5.26%	10.55%	9.86%	6.06%	4.81%
Pre Tax Income Margin	-1.16%	21.61%	-0.45%	4.52%	5.40%	13.41%	-0.45%	8.02%	5.40%	1.29%	0.36%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.84	13.84	0.94	1.63	1.76	0.00	0.00	0.00	1.76	0.00	0.00
NOPAT to Interest Expense	0.66	19.83	0.67	1.46	1.39	0.00	0.00	0.00	1.39	0.00	0.00
EBIT Less CapEx to Interest Expense	-0.08	12.47	-0.22	0.81	0.64	0.00	0.00	0.00	0.64	0.00	0.00
NOPAT Less CapEx to Interest Expense	-0.26	18.47	-0.49	0.63	0.27	0.00	0.00	0.00	0.27	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	263.11%	0.00%	41.93%	31.85%	9.40%	0.00%	0.00%	17.16%	16.56%	0.00%

Financials Breakdown Chart

Key Financial Trends

RH (NYSE: RH) has shown a blend of growing revenue and stable margins over the four-year window, but also carries a high debt load and a modest equity base. Here are the 10 most notable trends from the quarterly statements.

Revenue growth: RH’s quarterly revenue rose from about $811.7 million in Q3 2025 to about $883.8 million in Q3 2026, roughly a 9% year‑over‑year increase.
Gross margin stability: Gross margin stayed in the low to mid‑40s percent range across recent quarters (gross profit around $389.7 million on $883.8 million revenue in Q3 2026), indicating consistent cost control relative to revenue.
Earnings momentum: Net income and earnings per share improved in the latest period (Q3 2026 net income about $36.3 million; Basic EPS $1.93, Diluted EPS $1.83), versus the prior year’s quarter.
Operating cash flow strength: Key quarters show positive cash flow from continuing operating activities (example: roughly $86.6 million in Q1 2026 and similar in Q3 2026), signaling underlying cash generation.
Asset base growth: Total assets expanded to around $4.79 billion by Q3 2026, reflecting ongoing asset growth over the four-year period.
Liquidity snapshot: In Q3 2026, current assets (~$1.12B) exceed current liabilities (~$946M), indicating positive working capital, though quarterly levels fluctuate.
Debt composition note: Long‑term debt remains sizable (around $2.44 billion by late 2025/early 2026), implying a persistent leverage burden.
High leverage risk: Total liabilities approach about $4.79 billion while equity remains relatively small, suggesting substantial financial leverage and solvency sensitivity.\"
Persistent deficits in retained earnings: Retained earnings frequently show deficits, reflecting ongoing losses that erode accumulated equity over time.
Near‑term liquidity concerns: Cash and equivalents are relatively modest (around $43 million in Q3 2026) versus a multi‑billion liability base, which could stress liquidity in downturns or if cash generation slows.

05/15/26 08:15 AM ETAI Generated. May Contain Errors.

RH Financials - Frequently Asked Questions

According to the most recent income statement we have on file, RH's financial year ends in February. Their financial year 2025 ended on February 1, 2025.

RH's net income appears to be on an upward trend, with a most recent value of $72.41 million in 2025, falling from $91.00 million in 2014. The previous period was $127.56 million in 2024. Check out RH's forecast to explore projected trends and price targets.

RH's total operating income in 2025 was $322.59 million, based on the following breakdown:

Total Gross Profit: $1.41 billion
Total Operating Expenses: $1.09 billion

Over the last 10 years, RH's total revenue changed from $1.87 billion in 2014 to $3.18 billion in 2025, a change of 70.3%.

RH's total liabilities were at $4.72 billion at the end of 2025, a 6.2% increase from 2024, and a 473.2% increase since 2014.

In the past 10 years, RH's cash and equivalents has ranged from $5.80 million in 2018 to $2.18 billion in 2021, and is currently $30.41 million as of their latest financial filing in 2025.

Over the last 10 years, RH's book value per share changed from 17.76 in 2014 to -8.79 in 2025, a change of -149.5%.

Related Companies

Financial statements for NYSE:RH last updated on 4/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RH (RH) Financials

Financials Breakdown Chart

Key Financial Trends

RH Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

RH (RH) Financials

Annual Income Statements for RH

Quarterly Income Statements for RH

Annual Cash Flow Statements for RH

Quarterly Cash Flow Statements for RH

Annual Balance Sheets for RH

Quarterly Balance Sheets for RH

Annual Metrics And Ratios for RH

Quarterly Metrics And Ratios for RH

Financials Breakdown Chart

Key Financial Trends

RH Financials - Frequently Asked Questions

When does RH's fiscal year end?

How has RH's net income changed over the last 10 years?

What is RH's operating income?

How has RH's revenue changed over the last 10 years?

How much debt does RH have?

How much cash does RH have?

How has RH's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools